Keyphrases
Pancreatic Adenocarcinoma
100%
Prognostic Factors
100%
Selection Criteria
100%
Hepatic Lymph Node
100%
Confidence Interval
85%
Pancreaticoduodenectomy
71%
Lymph Node Metastasis
42%
Hazard Ratio
42%
Lymph Node Positive
42%
Median Overall Survival
28%
Disease-free Survival
28%
Histology
14%
Multivariate Analysis
14%
Further Analysis
14%
Consecutive Patients
14%
Overall Survival
14%
No Significant Difference
14%
Lymph Node Status
14%
Lymph Node Ratio
14%
Log-rank Test
14%
Louisville
14%
Disease Survival
14%
Poor Differentiation
14%
Multivariate Cox Proportional Hazard Regression
14%
Node-positive Disease
14%
Kaplan-Meier Analysis
14%
Difference in Medians
14%
Hepatopancreaticobiliary
14%
Lymph Node Disease
14%
Medicine and Dentistry
Pancreas Adenocarcinoma
100%
Lymph Node
100%
Prognostic Factor
100%
Common Hepatic Artery
100%
Pancreaticoduodenectomy
71%
Lymph Node Metastasis
42%
Hazard Ratio
42%
Overall Survival
42%
Disease
28%
Disease Free Survival
28%
Multivariate Analysis
14%
Kaplan Meier Method
14%
Proportional Hazards Model
14%
Lymphadenopathy
14%
Log Rank Test
14%
Pharmacology, Toxicology and Pharmaceutical Science
Pancreas Adenocarcinoma
100%
Overall Survival
100%
Lymph Node Metastasis
100%
Disease
66%
Disease Free Survival
66%
Lymphadenopathy
33%